Advertisement
U.S. markets close in 3 hours 2 minutes
  • S&P 500

    5,250.76
    +2.27 (+0.04%)
     
  • Dow 30

    39,765.82
    +5.74 (+0.01%)
     
  • Nasdaq

    16,378.56
    -20.96 (-0.13%)
     
  • Russell 2000

    2,128.58
    +14.23 (+0.67%)
     
  • Crude Oil

    82.76
    +1.41 (+1.73%)
     
  • Gold

    2,243.60
    +30.90 (+1.40%)
     
  • Silver

    25.00
    +0.25 (+1.00%)
     
  • EUR/USD

    1.0801
    -0.0028 (-0.26%)
     
  • 10-Yr Bond

    4.1910
    -0.0050 (-0.12%)
     
  • dólar/libra

    1.2634
    -0.0004 (-0.03%)
     
  • USD/JPY

    151.3350
    +0.0890 (+0.06%)
     
  • Bitcoin USD

    70,605.88
    +1,507.88 (+2.18%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Nikkei 225

    40,168.07
    -594.66 (-1.46%)
     

Coherus BioSciences to Report Second Quarter 2021 Financial Results on August 5th

REDWOOD CITY, Calif., July 26, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that its second quarter 2021 financial results will be released after market close on Thursday, August 5, 2021. Starting at 5 p.m. ET, Coherus’ management team will host a conference call and webcast to discuss financial results and provide a general business update.

After releasing second quarter financial results, the Company will post them on the Coherus website at https://investors.coherus.com.

Conference Call Information

When: Thursday, August 5, 2021 starting at 5:00 p.m. ET

Dial-in: (844) 452-6826 (Toll-Free U.S. and Canada) or (765) 507-2587 (International)

Conference ID: 9146617

Webcast: https://investors.coherus.com/upcoming-events

Please dial-in 15 minutes early to ensure a timely connection to the call.

About Coherus BioSciences
Coherus is a commercial stage biopharmaceutical company with the mission to increase access to cost-effective medicines that can have a major impact on patients’ lives and to deliver significant savings to the health care system. For additional information, please visit www.coherus.com.

CONTACT: Contact Information: Investor Contact: McDavid Stilwell, CFO Coherus BioSciences, Inc. IR@coherus.com


Advertisement